Skip to Content
Merck
All Photos(1)

Key Documents

Safety Information

44897-U

Supelco

ASTM® D6584 Tricaprin Solution

greener alternative

8000 μg/mL in pyridine, analytical standard

Synonym(s):

Biodiesel impurity

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

CAS Number:
621-71-6
EC Number:
203-809-9
UNSPSC Code:
41116107
NACRES:
NA.24

grade

analytical standard

Agency

ASTM® D6584

form

liquid

packaging

pkg of 1 × 5 mL

greener alternative product characteristics

Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

sustainability

Greener Alternative Product

concentration

8000 μg/mL in pyridine

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

application(s)

petroleum

format

single component solution

greener alternative category

Enabling,

storage temp.

2-8°C

InChI

1S/C33H62O6/c1-4-7-10-13-16-19-22-25-31(34)37-28-30(39-33(36)27-24-21-18-15-12-9-6-3)29-38-32(35)26-23-20-17-14-11-8-5-2/h30H,4-29H2,1-3H3

InChI key

LADGBHLMCUINGV-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Legal Information

ASTM is a registered trademark of American Society for Testing and Materials

Pictograms

FlameExclamation mark
GHS02,GHS07

Signal Word

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2 - Skin Irrit. 2

Storage Class Code

3 - Flammable liquids

WGK

WGK 2

Flash Point(F)

68.0 °F - closed cup

Flash Point(C)

20 °C - closed cup

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

FSL

Group 4: Flammable liquids
Type 1 petroleums
Hazardous rank II
Water insoluble liquid

ISHL Indicated Name

Substances Subject to be Indicated Names

ISHL Notified Names

Substances Subject to be Notified Names

JAN Code

44897-U:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCBX0146
BCBV0564
BCBR5427V
SZBF253XV
SZBF027XV

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

J F Horowitz et al.
Journal of applied physiology (Bethesda, Md. : 1985), 88(1), 219-225 (2000-01-21)
This investigation determined whether ingestion of a tolerable amount of medium-chain triglycerides (MCT; approximately 25 g) reduces the rate of muscle glycogen use during high-intensity exercise. On two occasions, seven well-trained men cycled for 30 min at 84% maximal O(2)
K Shirai et al.
Metabolism: clinical and experimental, 41(11), 1161-1164 (1992-11-01)
We have previously reported lipoprotein lipase with a defect of lipid-interface recognition in a patient with type I hyperlipoproteinemia. In this patient, lipoprotein lipase from post-heparin plasma (PHP) hydrolyzed monomeric substrate tributyrin, but scarcely hydrolyzed triolein emulsified with Triton X-100
Physical behavior of lipase substrates.
D M Small
Methods in enzymology, 286, 153-167 (1997-01-01)
F Kang et al.
AAPS PharmSciTech, 2(4), 30-30 (2004-01-20)
The purpose of this study was to investigate the effect of 2 additives, poly(ethylene glycol) (PEG) 1000 and 1,2,3-tridecanoyl glycerol (tricaprin), on the physico-chemical characteristics and in vitro release of a model protein, bovine serum albumin (BSA), form poly(D,L-lactic-co-glycolic acid)
Elisabetta Esposito et al.
Pharmaceutical research, 25(7), 1521-1530 (2008-01-04)
The present investigation describes a formulative study for the development of innovative drug delivery systems for bromocriptine. Solid lipid nanoparticles (SLN) based on different lipidic components have been produced and characterized. Morphology and dimensional distribution have been investigated by electron
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service